Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
Date
This item will be available on:
Authors
Boykin, Christi
Zhang, G.
Chen, Yan-Hua
Zhang, R-W
Fan, X-E
Yang, W-M
Lu, Q.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
British Journal of Cancer; 104:5 p. 781-789
item.page.doi
10.1038/bjc.2011.10